69462 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

September 1, 2010 (75 FR 53719), 

Noramco Inc., 1440 Olympic Drive, 

Athens, Georgia 30601, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of Poppy 

Straw Concentrate (9670), a basic class 

of controlled substance listed in 

schedule II. 

The company plans to import the 

listed controlled substance in bulk to 

manufacture other controlled substances 

solely in bulk for distribution to the 

company’s customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Noramco Inc. to import the basic class 

of controlled substance is consistent 

with the public interest, and with 

United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. DEA 

has investigated Noramco Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28513 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated August 2, 2010, and 

published in the Federal Register on 

September 1, 2010 (75 FR 53718), 

Cambrex Charles City, Inc., 1205 11th 

Street, Charles City, Iowa 50616, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Opium, raw (9600) ....................... II 

Drug Schedule 

Poppy Straw Concentrate (9670) II 

The company plans to import the 

basic classes of controlled substances to 

manufacture a bulk intermediate which 

will be distributed in bulk to the 

company’s customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Cambrex Charles City, Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. DEA 

has investigated Cambrex Charles City, 

Inc. to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28512 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By a Notice dated June 17, 2010, and 

published in the Federal Register on 

June 28, 2010 (75 FR 36680), Rhodes 

Technologies, 498 Washington Street, 

Coventry, Rhode Island 02816, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of the basic 

classes of controlled substances listed in 

schedule II: 

Drug Schedule 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670).

II 

The company plans to import the 

listed controlled substances in order to 

bulk manufacture controlled substances 

in Active Pharmaceutical Ingredient 

(API) form. The company distributes the 

manufactured API’s in bulk form only to 

its customers. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Rhodes Technologies to import the basic 

classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. DEA 

has investigated Rhodes Technologies to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28509 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated June 17, 2010, and 

published in the Federal Register on 

June 28, 2010, (75 FR 36683), 

Boehringer Ingelheim Chemicals, Inc., 

2820 N. Normandy Drive, Petersburg, 

Virginia 23805, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Phenylacetone (8501), a 

basic class of controlled substance listed 

in schedule II. 

The company plans to import the 

listed controlled substance to bulk 

manufacture amphetamine. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Boehringer Ingelheim Chemicals, Inc. to 

import the basic class of controlled 

substance is consistent with the public 

interest and with United States 

obligations under international treaties, 

conventions, or protocols in effect on 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 69463 

May 1, 1971. DEA has investigated 

Boehringer Ingelheim, Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28507 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated June 17, 2010 and 

published in the Federal Register on 

June 28, 2010, (75 FR 36681), Alltech 

Associates Inc., 2051 Waukegan Road, 

Deerfield, Illinois 60015, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedules I and II: 

Drug Schedule 

Methcathinone (1237) .................................................................................................................................................................................. I 

N-Ethylamphetamine (1475) ........................................................................................................................................................................ I 

N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I 

4-Methylaminorex (cis isomer) (1590) ......................................................................................................................................................... I 

Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I 

3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 

3,4-Methylenedioxymethamphetamine (MDMA) (7405) .............................................................................................................................. I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Bufotenine (7433) ........................................................................................................................................................................................ I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I 

N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... I 

1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... I 

1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I 

Dihydromorphine (9145) .............................................................................................................................................................................. I 

Normorphine (9313) .................................................................................................................................................................................... I 

Methamphetamine (1105) ........................................................................................................................................................................... II 

1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II 

Phencyclidine (7471) ................................................................................................................................................................................... II 

Phenylacetone (8501) ................................................................................................................................................................................. II 

1-Piperidinocyclohexanecarbo 

nitrile (8603).

II 

Cocaine (9041) ............................................................................................................................................................................................ II 

Codeine (9050) ............................................................................................................................................................................................ II 

Dihydrocodeine (9120) ................................................................................................................................................................................ II 

Ecgonine (9180) .......................................................................................................................................................................................... II 

Meperidine intermediate-B (9233) ............................................................................................................................................................... II 

Noroxymorphone (9668) .............................................................................................................................................................................. II 

The company plans to manufacture 

high purity drug standards used for 

analytical applications only in clinical, 

toxicological, and forensic laboratories. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Alltech Associates, Inc. to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Alltech Associates Inc. to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823(a), 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

mstockstill on DSKH9S0YB1PROD with NOTICES